6th Year Perspective: APPE Rotations at the Westcheste...
February 1, 2023 - Featured , Professional Advice / Opinions Featuring: Justin Budz, PharmD Candidate c/o 2023By: Isabelle Lim, PharmD Candidate c/o 2024 Justin Budz is a sixth-year pharmacy student at St. John’s University. While at St. John’s, Justin participated in multiple organizations, which ultimately led him to discover the career path he wanted to pursue. Most notably, Justin served as the Development and Outreach… |
|
Assessing the Efficacy of Cholecalciferol Versus Ergoca...
February 1, 2023 - Clinical , Featured By: Nancy Yousry, PharmD Candidate c/o 2024 Vitamin D is a multifaceted nutrient needed to maintain homeostasis and proper health. In addition to its role in building and maintaining healthy bones, vitamin D also regulates many important cellular functions in the body, serving as an anti-inflammatory, antioxidative, and neuroprotective agent.1 In general, the two… |
|
Evaluating Efficacy of Bortezomib and Carfilzomib in Tr...
February 1, 2023 - Clinical , Featured By: Brian Chung, PharmD Candidate c/o 2024, Peter Chung, PharmD Candidate c/o 2024, and Kevin Kim, PharmD Candidate c/o 2024 Multiple myeloma is a blood cancer that affects an individual’s plasma cells. Plasma cells are white blood cells located in the bone marrow that are responsible for producing antibodies, also known as immunoglobulins.1 Immunoglobulins… |
|
Evaluating Treatments and Preventative Measuresfor Monk...
February 1, 2023 - Featured , In the News / Politics By: Sairah Sheikh, PharmD Candidate c/o 2024 As Coronavirus Disease 2019 (COVID-19) cases started to decrease in the United States (US), many Americans breathed a sigh of relief. However, on May 17, 2022, fear of a new infectious disease struck the nation. The first case of the monkeypox outbreak in the US was reported… |
|
FDA Approval of Pemazyre® as a First-in-Class Treatmen...
February 1, 2023 - Featured , In the News / Politics By: Jennifer Galvet, PharmD Candidate c/o 2024 Fibroblast growth factor receptors (FGFRs) are a family of receptor tyrosine kinases expressed on the cell surface of both developmental and adult cells. Aberrant expression of FGFRs has been implicated in a wide variety of cancers and is considered an oncogenic signaling pathway.1 FGFRs are activated by… |
|
Relyvrio: A New FDA-Approved Medication for Amyotrophic...
February 1, 2023 - Featured , In the News / Politics By: Yu Jeng Lee, PharmD Candidate c/o 2023 Amyotrophic lateral sclerosis (ALS), also referred to as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects both the upper motor neurons (UMN) and lower motor neurons (LMN). This disease causes muscle weakness, which progresses to disability, and subsequently death, primarily due to respiratory failure.1,2 … |
|
Rho Chi Talks: Tips to Acquire a Post-Doctoral Fellowsh...
February 1, 2023 - Featured , Professional Advice / Opinions Featuring: Kamran Khan, PharmD Candidate c/o 2023By: Justin Budz, PharmD Candidate c/o 2023 Kamran Khan is a sixth-year pharmacy student at St. John’s University. Growing up, Kamran had a lot of family members in healthcare, instilling an interest in medicine from an early age. While at St. John’s, Kamran got to experience many different career… |